UFC Seattle fighter removed after positive drug test
MMA Fighting
February 20, 2026
AI-Generated Deep Dive Summary
Carol Foro was removed from her UFC debut after testing positive for an unnamed diuretic during an out-of-competition test conducted on January 6. The former Jungle Fight flyweight champion had been scheduled to face Stephanie Luciano at the UFC Seattle event on March 28 but was replaced by Alexia Thainara following the positive result. Foro and her team have denied any intentional use of banned substances, stating that the presence of the diuretic in her system does not align with a typical case of accidental contamination.
Foro’s team explained that they submitted a supplement for testing, which the UFC chose to exclude her from the event due to the time required for analysis and evaluation. The team emphasized their commitment to clean sport and responsible transparency while reaffirming their dedication to upholding UFC regulations. They also stressed the importance of allowing the technical investigation to proceed without interference.
The incident highlights the stringent drug testing policies in MMA, particularly under the UFC’s jurisdiction. While Foro maintains her innocence, the case underscores the challenges athletes face with substance use and contamination claims. The outcome could impact Foro’s budding career, as well as the credibility of her team and the sport as a whole. Sports fans interested in fair competition will likely follow the investigation closely to understand how such cases are resolved and the implications for athlete accountability.
This situation also raises questions about the transparency of drug testing procedures and the burden of proof required when substances like diuretics appear in an athlete’s system. Foro’s case adds another layer to the ongoing debate about accidental contamination versus intentional use, potentially influencing how UFC and other organizations handle similar situations in the future.
Verticals
sportsmma
Originally published on MMA Fighting on 2/20/2026